Turnaround Potential | Management expects to collect extended payment terms in early 2026, potentially restoring positive cash generation despite EBITDA-based valuation appearing attractive |
Generic Threat | Intensifying competition from generic producers erodes margins and pricing power, forcing extended payment terms that strain financial flexibility |
Analyst Targets | Price targets range from $13 to $22, reflecting deep concerns about profitability as earnings estimates plunge from $4.31 to $1.87 per share for FY2026 |
Cash Flow Crisis | FMC struggles with negative free cash flow for three consecutive years, facing a $400M reduction in Q3 amid working capital management challenges |

Metrics to compare | FMC | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipFMCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | 14.1x | 3.7x | |
PEG Ratio | 0.00 | 0.07 | 0.00 | |
Price / Book | 0.8x | 1.5x | 1.6x | |
Price / LTM Sales | 0.4x | 1.0x | 1.3x | |
Upside (Analyst Target) | 25.1% | 27.1% | 40.1% | |
Fair Value Upside | Unlock | −4.6% | 1.5% | Unlock |
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.